AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

Together with a team of international clinical researchers, Professor Dr Oliver A. Cornely and Dr Rosanne Sprute from University Hospital Cologne have published the new global guideline for the ...

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

On Valentine's Day, the Greenville Humane Society asked the community to help raise funds for a rescued dog's treatment.

Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

Diseases caused by Candida are among the most common fungal infections worldwide / The new guideline was developed over four years by a team of more than one hundred experts from 35 countries, led by ...

Together with a team of international clinical researchers, Professor Dr Oliver A. Cornely and Dr Rosanne Sprute from University Hospital Cologne have ...

Dr. Kara Hamilton of Black Hills Pediatrics joins us this week to provide everything you need to know about ear infections.

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.